Cannon Global Investment Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Cannon Global Investment Management, LLC

  • $57.1 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 19, 2023
SELL
$98.98 - $115.74 $49,490 - $57,870
-500 Reduced 3.7%
13,000 $1.5 Billion
Q2 2023

Jul 20, 2023
BUY
$96.34 - $112.38 $1.3 Million - $1.52 Million
13,500 New
13,500 $1.39 Billion
Q1 2022

May 02, 2022
SELL
$86.42 - $109.81 $691,360 - $878,480
-8,000 Closed
0 $0
Q4 2021

Feb 04, 2022
BUY
$98.56 - $119.91 $295,680 - $359,730
3,000 Added 60.0%
8,000 $862,000
Q3 2021

Oct 27, 2021
BUY
$91.91 - $110.37 $459,550 - $551,850
5,000 New
5,000 $548,000

Others Institutions Holding HZNP

# of Institutions
38
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Cannon Global Investment Management, LLC Portfolio

Follow Cannon Global Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannon Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cannon Global Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email